FUSAFUNGIN THERAPY OF ACUTE LARYNGITIS - A PHASE-IV STUDY

Four-hundred and eighty-four patients with acute laryngitis were exami ned before and after treatment with fusafungin under phase IV conditio ns. After one week of therapy such complaints as hoarseness, sore thro at and difficulties in swallowing were improved in about 90% of the pa tients, while the leading complaint of ''hoarseness'' had disappeared in 60%. Inflammatory findings, documented by a physician, showed compa rable results. An analysis of subgroups (ineffectively treated patient s and patients with long-lasting symptoms and complaints) shows that f usafungin was effective therapeutically for treating for acute laryngi tis. This study also shows that the generally accepted high rate of sp ontaneous recovery does not exist.